Recurrent thrombosis in a multiple myeloma patient with low risk for thrombosis despite being on thromboprophylaxis
Archives of Hematology Case Reports and Reviews · 2019
DOI: 10.17352/ahcrr.000015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Hematology Case Reports and Reviews, 2019. Verfasst von Kian CS und 1 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
It is a well-known fact that multiple myeloma (MM) patients have an increased risk for thromboembolic events involving both the venous and arterial territories.The etiologies can be multifactorial, for example, activation of procoagulant factors, acquired protein C resistance, MM-specifi ed and treatment-related factors.The risk of venous thrombosis is high when patients receive treatment with thalidomide or lenalidomide in combination with dexamethasone or multi-agent chemotherapy.Arterial thromboses occur less compared to venous thrombotic events.Nonetheless, thromboprophylaxis is important in preventing both types of thromboses.In this case study, we reveal a patient whom thrombosis occurred concurrently in both arterial and venous despite being on aspirin prophylaxis.
Zitieren
APA
CS, K., & FM, S. (2019). Recurrent thrombosis in a multiple myeloma patient with low risk for thrombosis despite being on thromboprophylaxis. Archives of Hematology Case Reports and Reviews. https://doi.org/10.17352/ahcrr.000015
Vancouver
CS K, FM S. Recurrent thrombosis in a multiple myeloma patient with low risk for thrombosis despite being on thromboprophylaxis. Archives of Hematology Case Reports and Reviews. 2019. doi:10.17352/ahcrr.000015
BibTeX
@article{CS2019,
author = {CS, Kian and FM, Sian},
title = {Recurrent thrombosis in a multiple myeloma patient with low risk for thrombosis despite being on thromboprophylaxis},
journal = {Archives of Hematology Case Reports and Reviews},
year = {2019},
doi = {10.17352/ahcrr.000015}
}
EUVIMED